World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
63756
World Ranking
11487
National Ranking
5888

Research.com Recognitions

  • 1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Jerry S. Wolinsky is affiliated with The University of Texas Health Science Center at Houston in the United States. Their primary field of study is Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Neurology, Rheumatology, Genetics, and Hematology.

Wolinsky's research broadly covers topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Rheumatoid Arthritis Research and Therapies, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia Research, and Systemic Lupus Erythematosus Research.

Frequent co-authors collaborating with Wolinsky include:

  • Ludwig Kappos
  • Douglas L. Arnold
  • Xavier Montalbán
  • Gary Cutter
  • Fred Lublin

Major publication venues for their work comprise:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Revue Neurologique
  • Multiple Sclerosis Journal - Experimental Translational and Clinical

Recent papers authored or co-authored by Wolinsky demonstrate contributions primarily in multiple sclerosis research. These include:

  • Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial, 2020, The Lancet Neurology
  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials, 2020, JAMA Neurology
  • Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis, 2021, Neurology
  • Five years of ocrelizumab in relapsing multiple sclerosis, 2020, Neurology
  • Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study, 2020, CNS Drugs

Jerry S. Wolinsky received recognition as a Fellow of the American Association for the Advancement of Science (AAAS) in 1996.

Best Publications

  • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

    Chris H Polman;Stephen C Reingold;Brenda Banwell;Michel Clanet

  • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

    W. Ian McDonald;Alistair Compston;Gilles Edan;Donald E Goodkin

  • Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

    Chris H. Polman;Stephen C. Reingold;Gilles Edan;Massimo Filippi

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis Results of a phase III multicenter, double‐blind, placebo‐controlled trial

    K. P. Johnson;B. R. Brooks;J. A. Cohen;C. C. Ford

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

    Paul O'Connor;Jerry S Wolinsky;Christian Confavreux;Giancarlo Comi

  • European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

    Giancarlo Comi;Massimo Filippi;Jerry S. Wolinsky

  • Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

    Kenneth P. Johnson;B. R. Brooks;Jeffrey A Cohen;C. C. Ford

  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Christian Confavreux;Paul O'Connor;Giancarlo Comi;Mark S. Freedman

  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.

    Ludwig Kappos;Jerry S. Wolinsky;Gavin Giovannoni;Douglas L. Arnold

  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

    Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  • Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

    Fred Lublin;David H Miller;Mark S Freedman;Bruce A C Cree

  • The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

    Franz Fazekas;F. Barkhof;M. Filippi;R. I. Grossman

  • Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial:

    Patrick Vermersch;Anna Czlonkowska;Luigi M E Grimaldi;Christian Confavreux

  • Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

    Ponnada A. Narayana;Timothy J. Doyle;Dejian Lai;Jerry S. Wolinsky

  • Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

    Jack H. Simon;D. Li;A. Traboulsee;P. K. Coyle

  • Isolation of metabolically active capillaries from rat brain.

    G. W. Goldstein;G. W. Goldstein;J. S. Wolinsky;J. S. Wolinsky;Judit Csejtey;Judit Csejtey;I. Diamond;I. Diamond

  • Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.

    G. M. McKhann;J. W. Griffin;David Cornblath;E. D. Mellits

Frequent Co-Authors

Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Ponnada A. Narayana
Ponnada A. Narayana The University of Texas Health Science Center at Houston
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Fred D. Lublin
Fred D. Lublin Icahn School of Medicine at Mount Sinai
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital
Stephen L. Hauser
Stephen L. Hauser University of California, San Francisco
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are flexible online pathways to advance your career or switch specialties. Many schools now offer online dnp programs without clinicals, designed for working nurses who want to earn terminal degrees without a heavy on-site commitment.

If you’re seeking a quick entry into the medical field, accelerated lpn programs online make it possible to become a Licensed Practical Nurse faster, with coursework that fits busy schedules.

For those drawn to mental healthcare, psych np online programs offer a direct route to advanced nursing roles specializing in psychiatric and mental health services, often with flexible start dates and remote learning options.

Beyond clinical practice, a healthcare administration degree online opens doors to leadership, management, and business roles in healthcare organizations, supporting students who want to shape policy or operational decisions.

Exploring online degrees lets you tailor your education to your goals and lifestyle, making advanced credentials more accessible than ever before.

Best Scientists Citing Jerry S. Wolinsky

Trending Scientists

Recently Published Articles